- Report
- September 2026
- 189 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- August 2026
- 160 Pages
Global
From €2994EUR$3,320USD£2,567GBP
€3743EUR$4,150USD£3,209GBP
- Report
- September 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- October 2025
- 150 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- January 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 198 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 185 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 198 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 191 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 184 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 191 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 185 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 187 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 183 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 197 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- January 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP

Over the Counter (OTC) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are a class of medications used to reduce inflammation and pain. They are available without a prescription and are used to treat a variety of conditions, including headaches, muscle aches, arthritis, and menstrual cramps. NSAIDs work by blocking the production of certain chemicals in the body that cause inflammation and pain. Common OTC NSAIDs include ibuprofen, naproxen, and aspirin.
NSAIDs are generally safe and effective when taken as directed. However, they can cause side effects, such as stomach upset, nausea, and dizziness. People with certain medical conditions, such as kidney or liver disease, should not take NSAIDs without consulting their doctor.
Companies in the OTC NSAID market include Bayer, Pfizer, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more